N-[2-[(3'R,7'aR)-3',6',10,11b-tetramethyl-3-oxospiro[1,2,4,6,6a,6b,7,8,11,11a-decahydrobenzo[a]fluorene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-6-(3-phenylpropanoylamino)hexanamide
Grundinformationen
- CAS
306387-90-6- Standard-SMILES
CC1=C2CC3C(CC=C4CC(=O)CCC43C)C2CCC12O[C@@H]1CC(C)CN(CCNC(=O)CCCCCNC(=O)CCc3ccccc3)C1[C@H]2C- InChIKey
WDHRPWOAMDJICD-BWBMXWGBSA-N- Summenformel
- C44H63N3O4
- Durchschnittliche Molmasse
- 698 g/mol
- Monoisotopische Masse
- 697,4818575
Namen und Bezeichner
- Bevorzugter Name
- N-[2-[(3'R,7'aR)-3',6',10,11b-tetramethyl-3-oxospiro[1,2,4,6,6a,6b,7,8,11,11a-decahydrobenzo[a]fluorene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-6-(3-phenylpropanoylamino)hexanamide
- IUPAC
- N-[2-[(3'R,7'aR)-3',6',10,11b-tetramethyl-3-oxospiro[1,2,4,6,6a,6b,7,8,11,11a-decahydrobenzo[a]fluorene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-6-(3-phenylpropanoylamino)hexanamide
- Englischer Name
- 3-Keto-N-aminoethyl-Naminocaproyldihydrocinnamoyl Cyclopamine
- Summenformel
- C44H63N3O4
- Molmasse
- 697.999
Namen und Synonyme
KAAD-CyclopamineCyclopamine-KAAD306387-90-6N-[2-[(3'R,7'aR)-3',6',10,11b-tetramethyl-3-oxospiro[1,2,4,6,6a,6b,7,8,11,11a-decahydrobenzo[a]fluorene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-6-(3-phenylpropanoylamino)hexanamideSCHEMBL29379211DTXSID70587893WDHRPWOAMDJICD-BWBMXWGBSA-N3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamineEX-A12670AKOS030255534G91431N-{2-[(14xi,17xi,22xi,23R,25xi)-3-Oxo-8xi,9xi,10xi-17,23-epoxyveratraman-28-yl]ethyl}-6-(3-phenylpropanamido)hexanamide
Weitere Namen anzeigen
KAAD Cyclopamine,KAADCyclopamine3-Keto-N-aminoethyl-N’-aminocaproyldihydrocinnamoyl Cyclopamine3-Keto-N-aMinoethyl-N'-aMinocaproyldihydrocinnaMoyl CyclopaMine, >80%Benzenepropanamide, N-[6-[[2-[(3'R,3'aS,6'S,6aS,6bS,7'aR,2'R,11aS,11bR)-1,2,3,3',3'a,4,5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-3-oxospiro[9H-benzo[a]fluorene-9,2'(4'H)-furo[3,2-b]pyridin]-4'-yl]ethyl]amino]-6-oxohexyl]-
N-{2-[(8xi,9xi,10xi,14xi,17xi,22xi,23R,25xi)-3-Oxo-17,23-epoxyveratraman-28-yl]ethyl}-6-(3-phenylpropanamido)hexanamide
Datenbank-Bezeichner
- CAS
306387-90-6- PubChem CID
- 16760383
- DTXSID
DTXSID70587893
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 5,2
- Polarare Oberfläche (TPSA)
- 87,7 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 12
- Schwere Atome
- 51
- Formalladung
- 0
- Komplexität
- 1.370
Physikochemische Eigenschaften
- Siedepunkt
- 875.6 · 875.6±65.0 °C(Predicted)
- Dichte
- 1.15 · 1.15±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · Hygroscopic, -20°C Freezer, Under Inert Atmosphere
- Löslichkeit
- Chloroform: Slightly soluble; Methanol: Slightly soluble
- Aggregatzustand
- A solid
- pka
- 16.1 · 16.10±0.46(Predicted)
- Farbe
- White to light yellow
- CAS Datenbank
- 306387 · 306387-90-6
Chemie und Industrie
Anwendungen
VerwendenCyclopamine demonstrates teratogenic properties and has been shown to reverse effects ofoncogenic mutations in Smoothened and Patched.1 The KAAD derivative has shown 10-20 fold higher potency than cyclopamine in inhibition of -Galactosidase expression i
Anbieter16 Anbieter
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
上海陶素生化科技有限公司021-33632979 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
上海宏叶生物科技有限公司400-9205774 400-920-5774 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 · [email protected]
Aladdin Scientific[email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
BOC Sciences+1-631-485-4226 · [email protected]
ChemeGen 中国18818260767 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
Zugehörige Reaktionen
1
Notizen zur Verbindung
Wird geladen…